Ризедронат Тева 35 мг
Pajjiż: Iżrael
Lingwa: Russu
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
RISEDRONIC ACID AS SODIUM 35 MG
Disponibbli minn:
ABIC MARKETING LTD
Kodiċi ATC:
M05BA07
Għamla farmaċewtika:
TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
Grupp terapewtiku:
RISEDRONIC ACID
Indikazzjonijiet terapewtiċi:
Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.
Data ta 'l-awtorizzazzjoni:
2011-10-01
